BioSpace News Archive

Job Trends

Jacobs Named Lead Architect for Hunt Regional Healthcare Women’s Center

Jacobs has been selected as the architect to design the new Hunt Regional Medical Center addition and surgical suit renovation in Greenville, Texas, marking the first expansion of the facility in more than 10 years.

May 23, 2019
·
3 min read
Deals

TerrAscend Announces Record Revenue for the First Quarter of 2019

TerrAscend Corp. reported financial results for the first quarter ending March 31, 2019.

May 23, 2019
·
11 min read
Business

Trovagene Announces Research Collaboration with Nektar Therapeutics to Evaluate Efficacy of the Combination of Onvansertib and ONZEALD™ in Models of Colorectal Cancer

ONZEALD is currently being evaluated in a Phase 3 trial in patients with metastatic breast cancer and brain metastases

May 23, 2019
·
7 min read
Biotech Bay

Cardinal Analytx Closes $22 Million Series B Round

Round by John Doerr, GuideWell, Blue Shield California and Premera Blue Cross Will Support Accelerated Hiring and Continued Innovation to Meet Fast-Growing Customer Demand

May 23, 2019
·
3 min read
Business

Nektar Announces the Launch of Inheris Biopharma, Inc.

Nektar Therapeutics announced the formation of Inheris Biopharma, Inc., a wholly-owned subsidiary of Nektar and a CNS-focused company.

May 23, 2019
·
7 min read
Deals

Incyte to Present at Upcoming Investor Conference - May 23, 2019

Incyte Corporation announced that it will present at the 40th Annual Goldman Sachs Global Healthcare Conference on Tuesday, June 11, 2019 at 2:00 pm / 5:00 pm in Rancho Palos Verdes.

May 23, 2019
·
1 min read
Essity’s Investor Day 2019

Essity, the global hygiene and health company, is holding its Investor Day in Stockholm, Sweden.

May 23, 2019
·
1 min read
Deals

InDemand Interpreting Acquired by Stratus Video

InDemand Interpreting, a portfolio company of Health Enterprise Partners, announced its acquisition by Stratus Video, LLC, a portfolio company of Kinderhook, LLC.

May 23, 2019
·
3 min read
Drug Development

Cadent Therapeutics Receives Milestone Payment for Initiation of Phase 2 Trial of MIJ821 in Treatment-Resistant Depression

Cadent Therapeutics announced the receipt of the second milestone payment from Novartis following the initiation of a Phase 2 clinical study of MIJ821, a subtype selective NMDA receptor negative allosteric modulator, in development for treatment-resistant depression.

May 23, 2019
·
2 min read
Pharm Country

Acorda Therapeutics to Present at Jefferies 2019 Healthcare Conference

Acorda Therapeutics, Inc. announced that Ron Cohen, M.D., Acorda’s President and Chief Executive Officer, will present at the Jefferies 2019 Healthcare Conference on Wednesday, June 5 at 8:00AM EST.

May 23, 2019
·
3 min read